In the Research Letter entitled “Association Between KRAS Variant Status and Outcomes With First-Line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer,”1 “Miles Tan” should be “Miles Hsu.” This article was corrected online.
Reference
- 1.Sun L, Hsu M, Cohen RB, Langer CJ, Mamtani R, Aggarwal C. Association between KRAS variant status and outcomes with first-line immune checkpoint inhibitor–based therapy in patients with advanced non–small-cell lung cancer. JAMA Oncol. Published online April 15, 2021. doi: 10.1001/jamadermatol.2021.0546 [DOI] [PMC free article] [PubMed] [Google Scholar]